Other Species / Isoforms
  PLM (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
C60-pa
LIILSKRcRcKFNQQ
1 0
PLM (human) under review -
PLM (mouse) under review -
PLM (rat) LIILSKRcRcKFNQQ C60-pa
PLM (dog) under review -
C62-pa
ILSKRcRcKFNQQQR
1 0
PLM (human) under review -
PLM (mouse) under review -
PLM (rat) ILSKRcRcKFNQQQR C62-pa
PLM (dog) under review -
T79-p
EPDEEEGtFRSsIRR
0 15
PLM (human) EPDEEEGtFRssIRR T79-p
PLM (mouse) EPDEEEGtFRssIRR T79-p
PLM (rat) EPDEEEGtFRSsIRR T79-p
PLM (dog) EPDEEEGTFRSsIRR T79
S82
EEEGtFRSsIRRLst
0 15
PLM (human) EEEGtFRssIRRLst S82-p
PLM (mouse) EEEGtFRssIRRLss S82-p
PLM (rat) EEEGtFRSsIRRLst S82
PLM (dog) EEEGTFRSsIRRLst S82
S83-p
EEGtFRSsIRRLstR
Upstream
Downstream
20 80
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (rat)
Putative in vivo kinases:
  • PKACA (human)
  • PKCA (human)
Putative upstream phosphatases:
  • PPP2CA (human)
Regulatory protein:
  • PKCA (human)
Treatment
  • bisindolylmaleimide
  • colforsin
  • endothelin
  • formaldehyde
  • H-89
  • inhibitor-1
  • insulin
  • isoproterenol
  • NKH_477
  • okadaic_acid
  • phenylephrine
  • phorbol_ester
PLM (human) EEGtFRssIRRLstR S83-p
PLM (mouse) EEGtFRssIRRLssR S83-p
PLM (rat) EEGtFRSsIRRLstR S83-p
PLM (dog) EEGTFRSsIRRLstR S83-p
S88-p
RSsIRRLstRRR___
Upstream
Downstream
24 76
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
  • molecular association, regulation
Kinase, in vitro:
  • PKACA (human)
  • PKACA (rat)
  • PKCA (rat)
Putative in vivo kinases:
  • PKACA (human)
  • PKCA (human)
Putative upstream phosphatases:
  • PPP1CA (rat)
Treatment
  • bisindolylmaleimide
  • colforsin
  • endothelin
  • formaldehyde
  • H-89
  • inhibitor-1
  • insulin
  • isoproterenol
  • NKH_477
  • okadaic_acid
  • phenylephrine
  • phorbol_ester
  • racepinefrine
PLM (human) RssIRRLstRRR___ S88-p
PLM (mouse) RssIRRLssRRR___ S88-p
PLM (rat) RSsIRRLstRRR___ S88-p
PLM (dog) RSsIRRLstRRR___ S88-p
T89-p
SsIRRLstRRR____
Upstream
Downstream
8 50
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • endothelin
  • inhibitor-1
  • isoproterenol
  • okadaic_acid
  • phenylephrine
  • phorbol_ester
PLM (human) ssIRRLstRRR____ T89-p
PLM (mouse) ssIRRLssRRR____ S89-p
PLM (rat) SsIRRLstRRR____ T89-p
PLM (dog) SsIRRLstRRR____ T89-p